ImClone Investigational Site

Armonk, New York 10504

0 studies enrolling now · 2 studies all time

What they study most

Colorectal Cancer, Colorectal Neoplasms, Metastases, Neoplasm

Studies at this site

• Erbitux (Cetuximab) Given Alone to Patients With EGFR-Negative Metastatic Colon or Rectal Cancer That is Refractory to Chemotherapy — Completed
• Study of Cetuximab, Oxaliplatin, 5-FU/LV Versus Oxaliplatin, 5-FU/LV in Patients With Previously Treated Metastatic, EGFR-Positive Colorectal Cancer — Completed